Previous research results have shown that chemotherapy drugs can increase CD8+ TIL density,45 regulate the immune microenvironment,46 and upregulate the expression of PD-L1 in ESCC tumors,47,48 that may promote cancer cell susceptibility to immune therapy. Here, CD8A is linked to esophageal squamous cell carcinoma.